HLA DR15 (DR2) and DQB1*0602 typing studies in 188 narcoleptic patients with cataplexy

Neurology

Volumn 48, Issue 6, 1997, Pages 1550-1556

  Rogers, A E ^a   Meehan, J ^b   Guilleminault, C ^b   Grumet, F C ^c   Mignot, E ^b,d  

^a UNIVERSITY OF MICHIGAN   (United States)

^b STANFORD UNIVERSITY   (United States)

^c Stanford California and Cofounder   (United States)

^d STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DQ ANTIGEN; HLA DR ANTIGEN;

ARTICLE; CATAPLEXY; CLINICAL FEATURE; ETHNIC GROUP; FEMALE; HLA TYPING; HUMAN; MAJOR CLINICAL STUDY; MALE; NARCOLEPSY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SLEEP;

EID: 0030858847     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.48.6.1550     Document Type: Article

References (48)

1. Westfall C. Eigenthümliche mit Einschlafen verbundene Anfälle. Arch Psychiat 1877;7:631-635.
2. Baraitser M, Parkes J. Genetic study of the narcolepsy syndrome. J Med Genet 1978;15:254-259.
3. Yoss R, Daly D. Hereditary aspects of narcolepsy. Trans Am Neurol Assoc 1960;85:239-240.
4. Kessler S, Guilleminault C, Dement WC. A family study of 50 REM narcoleptics. Acta Neurol Scand 1979;50:503-512.
5. Honda Y, Asaka A, Tanaka Y, Juji T. Discrimination of narcolepsy by using genetic markers and HLA [abstract]. Sleep Research 1983;12:254.
6. Juji T, Satake M, Honda Y, Doi Y. HLA antigens in Japanese patients with narcolepsy - all the patients were DR2 positive. Tissue Antigens 1984;24:316-319.
7. Doran T, Rouse S, Hakos G, Honeyman M. FT31 may demonstrate a DQw1 variant in narcoleptic patients. In: Aizawa M, ed. HLA in Asia-Oceania 1986. Sapporo, Japan: Hokkaido University Press; 1986:783-786.
8. Langdon N, Welch KI, Van Dam M, Vaugham R, Parkes J. Genetic markers in narcolepsy. Lancet 1984;2:1178-1180.
9. Billiard M, Seignalet J. Extraordinary association between HLA-DR2 and narcolepsy. Lancet 1985;1:226-227.
10. Mueller-Eckhardt G, Meier-Ewert KA, Sehendel DJ, Reinecker FB, Mueller-Eckhardt C. HLA and narcolepsy in a German population. Tissue Antigens 1986;28:163-169.
11. Poirier G, Montplaisir J, Decary F, Momege D, Lebrun A. HLA antigens in narcolepsy and idiopathic central nervous system hypersomnolence. Sleep 1986;9:153-158.
12. Meier-Ewert K, Mueller-Eckhardt G, Schendel DJ. Narcolepsy and HLA in the Federal Republic of Germany: population and family data. In: Honda Y, Juji T, eds. HLA in narcolepsy. Berlin: Springer-Verlag, 1985:114-120.
13. Guilleminault C, Grumet C. HLA-DR2 and narcolepsy: not all narcoleptic-cataplectic patients are DR2. Hum Immunol 1986; 17:1-2.
14. Andreas-Zietz A, Keller E, Scholz S, et al. DR2 negative narcolepsy. Lancet 1986;2:685-686.
15. Confavreux C, Gebuhrer L, Betuel H, et al. HLA-DR2 negative narcolepsy. J Neurol Psychiatr 1987;50:635-643.
16. Neely S, Rosenberg R, Spire JP, Antel J, Arnason BEW. HLA antigens in narcolepsy. Neurology 1987;37:1178-1180.
17. Matsuki K, Honda Y, Juji T. Diagnostic criteria for narcolepsy and HLA-DR2 frequencies. Tissue Antigens 1987;30:155-160.
18. Honda Y. Introduction. In: Honda Y, Juju T, eds. HLA in narcolepsy. Berlin: Springer-Verlag, 1988:1-7.
19. Nezu S, Noji K, Tsutsumi Y, et al. An interim report about correlation of HLA antigens with narcolepsy. J Psychiatr Soc Kanagawa Prefecture 1985;35:81-86.
20. Honda Y, Matsuki K. Genetic aspects of narcolepsy. In: Thorpy MJ, ed. Handbook of sleep disorders. New York: Marcel Dekker, 1990:217-234.
21. Marsh GE. Nomenclature for factors of the HLA system, update February 1996. Tissue Antigens 1996;47:360.
22. Lin L, Kuwata S, Tokunaga K, Sasaki T, Honda Y, Juji T. In: Tsuji K, Aizawa M, Sasazuki T, eds. HLA 1991, Proceedings of the 11th International Histocompatibility Workshop and Conference (November 1991, Yokohama, Japan). Vol. 2. Oxford: Oxford University Press, 1992:333-335.
23. Kuwata S, Juji T, Sasaki T, et al. In: Tsuji K, Aizawa M, Sasazuki T, eds. HLA 1991, Proceedings of the 11th International Histocompatibility Workshop and Conference (November 1991, Yokohama, Japan). Vol. 2. Oxford: Oxford University Press, 1992:730-732.
24. Mignot E, Lin X, Arrigoni J, et al. DQB1*0602 and DQA1*0102 (DQ1) are better markers than DR2 for narcolepsy in Caucasian and black Americans. Sleep 1994;17:S60-S67.
25. Parkes JD, Langdon N, Lock C. Narcolepsy and immunity. BMJ 1986;292:359-360.
26. Carlander B, Eliaou JF, Billiard M. Autoimmune hypothesis in narcolepsy. Neurophysiol Clin 1993;23:15-22.
27. Mignot E, Tafti M, Dement WC, Grumet FC. Narcolepsy and immunity. Adv Neuroimmunol 1995;5:23-37.
28. Fredrikson S, Carlander B, Billiard M, Link H. CSF Immune variable in patients with narcolepsy. Acta Neurol Scand 1990; 81:253-254.
29. Matsuki K, Juji T, Honda Y. Immunological features in Japan. In: Honda Y, Juji T, eds. HLA in narcolepsy. Berlin: Springer-Verlag, 1988:58-76.
30. Rubin RL, Hajdukovitch RM, Mitler MM. HLA DR2 association with excessive somnolence in narcolepsy does not generalize to sleep apnea and is not accompanied by systemic autoimmune abnormalities. Clin Immunol Immunopathol 1988;49: 149-158.
31. Erlich SS, Itabashi HH. Narcolepsy: a neuropathological study. Sleep 1986;9:126-132.
32. Montplaisir J, Poirier G. HLA and narcolepsy in Canada. In: Honda Y, Juji T, eds. HLA in narcolepsy. Berlin: Springer-Verlag, 1988:97-113.
33. Tafti M, Nishino S, Aldrich MS, Dement WC, Mignot E. Narcolepsy is associated with increased microglia expression of MHC class II molecules. J Neurosci 1996;16:4588-4595.
34. Mignot E, Kimura A, Lattemnann A, et al. HLA class II studies in non DRB1*1501 patients with narcolepsy-cataplexy. In: Charon D. Fauchet R, eds. HLA 1996, Proceedings of the 12th International Histocompatibility Workshop and Conference: Genetic diversity of HLA: Functional and medical implications (June 1996, St. Malo, France). Vol. 1. Paris: EDK Press, 1996.
35. Mignot E, Kimura A, Lattermann A, et al. Extensive HLA Class II studies in 58 non DRB1*15 (DR2) narcoleptic patients with cataplexy maps susceptibility to the coding region of DQA1*0102 and DQB1*0602. Tissue Antigens (in press).
36. Hublin C, Partinen M, Kaprio J, Koskenvuo M, Guilleminault C. Epidemiology of narcolepsy. Sleep 1994;17:S7-12.
37. Lock CB, So AKL, Welch KI, Parkes JD, Trowsdale J. MHC class II sequences of an HLA-DR2 narcoleptic. Immunogenetics 1988;27:449-455.
38. Uryu N, Maeda M, Nagata Y, et al. No difference in the nucleotide sequence of the DQbeta betal domain between narcoleptic and healthy individuals with DR2, Dw2. Hum Immunol 1989;24:175-181.
39. Mignot E, Lin X, Kalil J, et al. DQB1-0602 (DQw1) is not present in most nonDR2 Caucasian narcoleptics. Sleep 1992; 15:415-422.
40. Partinen M, Hublin C, Kaprio J, Koskenvuo M, Guilleminault C. Twin studies in narcolepsy. Sleep 1994;17:S13-S16.
41. Hyduk R, Flodman P, Spence A, Erman MK, Miller MM. Monozygotic twins with narcolepsy: preliminary report [abstract]. Sleep Research 1996;25:252.
42. Diagnostic Classification Steering Committee. International classification of sleep disorders: diagnostic and coding manual. Rochester, MX: American Sleep Disorders Association, 1990.
43. Guilleminault C, Mignot E, Grumet C. Family study of narcolepsy. Lancet 1989;2:1376-1379.
44. Mignot E, Meehan J, Grumet FC, et al. HLA Class II and narcolepsy in thirty-three multiplex families (abstract). Sleep Research 1996;25:303.
45. Kimura A, Dong RP, Harada H, Sasazuki T. DNA typing of HLA class II genes in B-lymphoblastoid cell lines homozygous for HLA. Tissue Antigens 1992;40:5-12.
46. Acton R, Shettar S, Wise M, et al. A comparison of HLA-DR2 (DRB1-1501) and DQ6 (DQB1-0602) associations with narcolepsy and diagnostic features in Caucasian Americans and African Americans [abstract). Sleep Research 1995;24:184.
47. Singh SM, George CFP, Kryger MH. Genetic heterogeneity in narcolepsy. Lancet 1990;335:726-727.
48. Aldrich MS. The clinical spectrum of narcolepsy and idiopathic hypersomnia. Neurology 1996;46:393-401.